Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akili, Inc. - Common Stock (NQ: AKLI )

1.600 +0.030 (+1.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,551
Open 1.590
Bid (Size) 1.550 (3)
Ask (Size) 1.620 (25)
Prev. Close 1.570
Today's Range 1.526 - 1.600
52wk Range 0.8551 - 37.58
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Akili, Inc.
Via Business Wire

Performance

YTD
+45.45%
+45.45%
1 Month
-4.76%
-4.76%
3 Month
+42.86%
+42.86%
6 Month
-29.20%
-29.20%
1 Year
-77.62%
-77.62%

More News

Read More
Akili to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, March 7 at 4:30 p.m. ET
From Akili, Inc.
Via Business Wire
Akili to Participate in the Cowen 43rd Annual Health Care Conference
From Akili, Inc.
Via Business Wire
Where Akili Stands With Analysts
Via Benzinga
Expert Ratings for Akili
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 28, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference
From Akili, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Pivotal Trial of EndeavorRxⓇ in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes
From Akili, Inc.
Via Business Wire
Morgan Stanley Initiates Coverage On This Digital Therapeutics Stock With Attractive View
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer
From Akili, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Akili Reports Third Quarter 2022 Financial Results and Company Update
From Akili, Inc.
Via Business Wire
Financial Industry Veteran Mary Hentges Joins Akili’s Board of Directors
From Akili, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022
Via Benzinga
Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET
From Akili, Inc.
Via Business Wire
Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.